SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $41.17 | 52-week high | $45.62 |
Prev. close | $41.28 | 52-week low | $34.67 |
Day low | $41.06 | Volume | 11,100 |
Day high | $41.27 | Avg. volume | 40,200 |
50-day MA | $41.24 | Dividend yield | 1.43% |
200-day MA | $40.93 |
XPH Stock Price Chart Interactive Chart >
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Pharmaceuticals Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 198.08M |
Net Asset Value (NAV) | $41.26 |
Options? | Yes |
Total Holdings | 43 |
XPH Top Holdings
Symbol | Company | % of Total |
OGN | ORGANON + CO | 5.26% |
MRK | MERCK + CO. INC. | 4.99% |
ELAN | ELANCO ANIMAL HEALTH INC | 4.89% |
AXSM | AXSOME THERAPEUTICS INC | 4.87% |
PFE | PFIZER INC | 4.87% |
LLY | ELI LILLY + CO | 4.84% |
PRGO | PERRIGO CO PLC | 4.82% |
CTLT | CATALENT INC | 4.73% |
ITCI | INTRA CELLULAR THERAPIES INC | 4.73% |
VTRS | VIATRIS INC | 4.59% |
XPH Price Returns
1-mo | 5.29% |
3-mo | -8.44% |
6-mo | 12.55% |
1-year | 2.63% |
3-year | -13.36% |
5-year | 11.81% |
YTD | -0.68% |
2023 | 2.97% |
2022 | -9.83% |
2021 | -10.54% |
2020 | 14.68% |
2019 | 25.61% |
XPH Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |